2023
December
In a phase III trial, a new combination treatment with individualized cancer growth blocking drugs for leukaemia in adults was studied. More than 95 percent of the patients were in remission three years after the start of the treatment, considerably more than with standard treatment. related: #leukaemia #growth_blocker #combination |
See also on Mastodon @neat_news.